Vector Triangle Method

ALS gene therapy targeting TDP-43 protein put on FDA fast track

The FDA granted fast track status to VectorY’s VTx-002, an antibody gene therapy targeting TDP-43 protein aggregates in ALS.

Some results have been hidden because they may be inaccessible to you